Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FIORE: Empagliflozin vs Glimepiride on Myocardial Metabolism in T2DM
NCT04183868Phase 4Completed
- Sponsor
- University of Magna Graecia
- Start
- Apr 2016
- Primary completion
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of empagliflozin in type 2 diabetes mellitus (T2DM), sponsored by University of Magna Graecia. Started Apr 2016; status: completed.
02
Drugs
empagliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT04183868.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04183868.